Literature DB >> 14743896

Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.

Shamima Sultana1, Shoji Morishita, Kazuo Awai, Koichi Kawanaka, Yoichi Ohyama, Yoshiharu Nakayama, Masanori Imuta, Akihiko Arakawa, Yasuyuki Yamashita.   

Abstract

PURPOSE: To compare enhancement of the aorta, portal vein, liver, and tumor with contrast medium of a higher iodine concentration to that with one of a standard iodine concentration for liver dynamic CT within the same patient with known liver cirrhosis and hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Fifty-three patients with known cirrhosis and HCC underwent repeat computed tomographic (CT) examinations within three months, the first with either 300 (n=26) or 370 mgI/ml (n=27) of nonionic contrast material. In the second examination, only concentration was altered. In 28 patients, weight was equal to or more than 65 kg, and in 25 patients it was less than 65 kg. The CT numbers (HU) of the aorta, portal vein, liver, and tumor were obtained, and CT attenuation was compared between the two concentration studies. The degree of enhancement was scored qualitatively.
RESULTS: Mean enhancement values of the aorta, liver, portal vein, and tumor were greater with the 370 mgI/ml injections than with the 300 mgI/ml injections throughout the study. In visual analysis, the difference in aortic, portal venous, liver, and tumor enhancement was not statistically significant between the two groups in patients weighing less than 65 kg. However, in patients weighing 65 kg or more, strong aortic and portal venous enhancement (rated as good or excellent) occurred more frequently with the 370 mgI/ml injections than with the 300 mgI/ml injections.
CONCLUSION: Higher contrast enhancement was achieved in patients who received 370 mgI/ml of contrast material, resulting in better tissue contrast between liver parenchyma and HCCs. However, this difference was not visually significant in patients weighing less than 65 kg.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14743896

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  8 in total

1.  Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.

Authors:  Isao Yamaguchi; Eiji Kidoya; Masayuki Suzuki; Hirohiko Kimura
Journal:  Radiol Phys Technol       Date:  2010-09-25

2.  Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.

Authors:  A Guerrisi; D Marin; R C Nelson; G De Filippis; M Di Martino; H Barnhart; R Masciangelo; I Guerrisi; R Passariello; C Catalano
Journal:  Br J Radiol       Date:  2011-08       Impact factor: 3.039

3.  Contrast enhancement in multidetector-row computed tomography (MDCT) of the abdomen: intraindividual comparison of contrast media containing 300 mg versus 370 mg iodine per ml.

Authors:  F F Behrendt; A H Mahnken; S Keil; M Das; C Hohl; D Bauer; P Seidensticker; E Jost; J E Wildberger; R W Günther; G Mühlenbruch
Journal:  Eur Radiol       Date:  2008-01-29       Impact factor: 5.315

4.  Evaluation of the acute adverse reaction of contrast medium with high and moderate iodine concentration in patients undergoing computed tomography.

Authors:  Masashi Nagamoto; Tatsuya Gomi; Hitoshi Terada; Shigehiko Terada; Eiichi Kohda
Journal:  Radiat Med       Date:  2006-12-25

5.  A comparison of the use of contrast media with different iodine concentrations for multidetector CT of the kidney.

Authors:  Seung Chai Jung; Seung Hyup Kim; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

6.  Which Iodine concentration in chest CT?--a prospective study in 300 patients.

Authors:  Georg Mühlenbruch; Florian F Behrendt; Mohammed A Eddahabi; Christian Knackstedt; Sven Stanzel; Marco Das; Peter Seidensticker; Rolf W Günther; Joachim E Wildberger; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

7.  Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.

Authors:  Yumi Yanaga; Kazuo Awai; Yoshiharu Nakayama; Takeshi Nakaura; Yoshitaka Tamura; Yoshinori Funama; Masahito Aoyama; Naoki Asada; Yasuyuki Yamashita
Journal:  Radiat Med       Date:  2007-07-27

8.  Comparison of enhancement and image quality: different iodine concentrations for liver on 128-slice multidetector computed tomography in the same chronic liver disease patients.

Authors:  Byoung Goo Jo; Yun Gyu Song; Sang Goon Shim; Young Wook Kim
Journal:  Korean J Intern Med       Date:  2015-12-23       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.